ArticleMolecular biology reports2026
TP53 status is associated with differential stress-marker expression and APP maturation in colon cancer cells.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe systemic influence of tumor-derived secretomes on the nervous system remains poorly understood. We investigated whether differences in TP53 status are associated with altered cellular stress-handling states and amyloid precursor protein (APP) processing in colon cancer cells.
methodsAPP maturation, intracellular localization, and stress-associated signaling were analyzed in TP53 wild-type and TP53-mutant colon cancer cells using immunoblotting, confocal microscopy, and ELISA. Functional associations between APP processing, GPX4-associated pathways, and neurotoxicity were further evaluated using pharmacological and genetic perturbation approaches, followed by conditioned-medium transfer experiments in HT22 neuronal and BV2 microglial cells.
resultsDistinct patterns of APP maturation and intracellular localization were observed between colon cancer cells with different TP53 status. TP53-mutant cells preferentially processed APP into its mature form and displayed relatively higher GPX4 expression, whereas TP53 wild-type cells exhibited increased endoplasmic reticulum (ER) retention of immature APP, accompanied by reduced GPX4 and elevated ATF4 expression. Functional analyses further revealed that these distinct intracellular stress-associated states were accompanied by differential neurotoxic effects of tumor-derived conditioned media. Conditioned media derived from TP53 wild-type cells significantly reduced cell viability, decreased attached-cell density, and induced morphological deterioration in HT22 neuronal and BV2 microglial cells. In contrast, conditioned media derived from TP53-mutant cells exhibited comparatively reduced neurotoxicity. Conditioned media derived from isogenic TP53-null cells displayed similarly reduced neurotoxicity, further supporting an association between TP53 status and secretome-associated phenotypes.
conclusionCollectively, our findings suggest that differences in TP53 status are associated with distinct stress-associated signaling, APP maturation, and secretome-associated phenotypes, which may contribute to differential tumor-neural cross-talk mediated by tumor-derived secretomes.
Indexed as
Identifiers
42579179What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.